# Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma

> **NCT00283985** · PHASE2 · COMPLETED · sponsor: **University Hospital, Limoges** · enrollment: 40 (actual)

## Conditions studied

- Lymphoma, Non-Hodgkin

## Interventions

- **DRUG:** Kidrolase
- **DRUG:** Methotrexate
- **DRUG:** Dexamethasone
- **DRUG:** Erwinase

## Key facts

- **NCT ID:** NCT00283985
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00283985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00283985, "Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00283985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*